rhodamine WT

Also Known As:

xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, inner salt, sodium salt, hydrochloride (1:2:1); Ethanaminium, N-(9-(2,4-dicarboxyphenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-N-ethyl-, inner salt, sodium salt, hydrochloride (1:2:1)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Rhodamines: 466
        rhodamine WT: 2

Experts

1.	Adair, James H: 2 articles (01/2021 - 01/2021)
2.	Matters, Gail L: 2 articles (01/2021 - 01/2021)
3.	Abraham, Thomas: 1 article (01/2021)
4.	Adair, Bernadette M: 1 article (01/2021)
5.	Bussard, Karen M: 1 article (01/2021)
6.	Gigliotti, Christopher M: 1 article (01/2021)
7.	Gigliotti, Nicholas T: 1 article (01/2021)
8.	Linton, Samuel S: 1 article (01/2021)
9.	Liu, Zi-Kui: 1 article (01/2021)
10.	Loc, Welley S: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "Through specific interactions with CCK-B receptors, tumor-targeted nanoparticles containing either ICG or rhodamine WT were well distributed throughout the matrix of both pancreatic and prostate tumors. "
2.	Breast Neoplasms (Breast Cancer) 01/01/2021 - "Targeted anti-CD71-CPSNPs encapsulated with the fluorophore, Rhodamine WT, were preferentially internalized by breast cancer cells in co-cultures with osteoblasts. "

Related Drugs and Biologics

1.	Cholecystokinin B Receptor